Acino Holding AG (LTS:0QM8) OCF Margin %: 10.30% (As of Dec. 2013)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

What is Acino Holding AG OCF Margin %?

Acino Holding AG LTS:0QM8 OCF Margin % is 10.30% as of Dec. 2013.

OCF Margin % is calculated as Cash Flow from Operations divided by its Revenue. Acino Holding AG's Cash Flow from Operations for the six months ended in Dec. 2013 was CHF33.08 Mil. Acino Holding AG's Revenue for the six months ended in Dec. 2013 was CHF321.15 Mil. Therefore, Acino Holding AG's OCF Margin % for the quarter that ended in Dec. 2013 was 10.30%.

As of today, Acino Holding AG's current OCF Yield % is 0.00%.

The historical rank and industry rank for Acino Holding AG's OCF Margin % or its related term are showing as below:


LTS:0QM8's OCF Margin % is not ranked *
in the Drug Manufacturers industry.
Industry Median: 10.04
* Ranked among companies with meaningful OCF Margin % only.

Acino Holding AG OCF Margin % Related Terms

Acino Holding AG OCF Margin % Historical Data

* Premium members only.

The historical data trend for Acino Holding AG's OCF Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Acino Holding AG OCF Margin % Chart

Acino Holding AG Annual Data
Trend Dec04 Dec05 Dec06 Dec07 Dec08 Dec09 Dec10 Dec11 Dec12 Dec13
OCF Margin %
Get a 7-Day Free Trial Premium Member Only Premium Member Only 31.77 16.03 6.62 9.49 10.30

Acino Holding AG Semi-Annual Data
Dec03 Dec04 Dec05 Dec06 Dec07 Dec08 Dec09 Dec10 Dec11 Dec12 Dec13
OCF Margin % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only 31.77 16.03 6.62 9.49 10.30

Acino Holding AG OCF Margin % Calculation

OCF Margin % is the ratio of Cash Flow from Operations divided by net sales or Revenue, usually presented in percent.

Acino Holding AG's OCF Margin for the fiscal year that ended in Dec. 2013 is calculated as

OCF Margin=Cash Flow from Operations (A: Dec. 2013 )/Revenue (A: Dec. 2013 )
=33.084/321.15
=10.30 %

Acino Holding AG's OCF Margin for the quarter that ended in Dec. 2013 is calculated as

OCF Margin=Cash Flow from Operations (Q: Dec. 2013 )/Revenue (Q: Dec. 2013 )
=33.084/321.15
=10.30 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about OCF Margin % →
What does a OCF Margin % of 10.30% mean?
Acino Holding AG (LTS:0QM8) has a OCF Margin % of 10.30% as of Dec. 2013. OCF Margin is the ratio of Cash Flow from Operations to Total Revenue. View historical data on Acino Holding AG and its competitors.
Is Acino Holding AG's OCF Margin % too high?
Acino Holding AG's current OCF Margin % is 10.30%. The Drug Manufacturers industry median OCF Margin % is 10.04. Acino Holding AG's value of 10.30% is 2.6% above this industry median.
How does Acino Holding AG's OCF Margin % compare to competitors?
Acino Holding AG's OCF Margin % of 10.30% can be compared against companies in the Drug Manufacturers industry. The industry median OCF Margin % is 10.04. Acino Holding AG's value of 10.30% is 2.6% above this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good OCF Margin % for a Drug Manufacturers company?
The median OCF Margin % among Drug Manufacturers companies is 10.04, based on 962 companies in the industry. Companies in the top quartile (top 25%) have a OCF Margin % significantly above this median, while those in the bottom quartile fall well below. However, OCF Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Acino Holding AG's current OCF Margin % of 10.30% is 2.6% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high OCF Margin % mean?
A high OCF Margin % can signal that a stock is expensive relative to its fundamentals. OCF Margin is the ratio of Cash Flow from Operations to Total Revenue. View historical data on Acino Holding AG and its competitors. For the Drug Manufacturers industry, the median OCF Margin % is 10.04 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Acino Holding AG's current OCF Margin % is 10.30%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Acino Holding AG stock overvalued right now?
Acino Holding AG (LTS:0QM8) has a current OCF Margin % of 10.30%. The current OCF Margin % is 10.30% and 2.6% above the Drug Manufacturers industry median of 10.04. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is OCF Margin % calculated?
OCF Margin % is calculated from a company's financial statements. For Acino Holding AG (LTS:0QM8), the current OCF Margin % is 10.30% as of Dec. 2013. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Acino Holding AG Business Description

Acino Holding AG is a Switzerland-based company engaged in the pharmaceutical industry. The Company develops, manufactures, and markets pharmaceuticals in novel drug delivery forms internationally. It is divided into four segments Business to Consumer (BtC); Business to Business (BtB); Technology marketing (TM); and Production (Prod). The BtC segment comprises all direct marketing activities. Under the company's "Acino Switzerland" brand and, with the promise of Swiss quality, the company sells its products in emerging markets around the globe. This reporting segment includes the business purchased from Mepha/Cephalon in the Middle East, Africa, Latin America and Asia. The BtB segment comprises Acino's business with its internally developed products, for which the company also owns the intellectual property rights. Acino develops and produces high-quality medicines with proven active ingredients and modern drug delivery systems and grants licenses for them to leading pharmaceutical and generic pharmaceutical companies worldwide. The technology marketing segment comprises a broad spectrum of fully integrated contract services, including procurement, contract development, production and packaging for companies in the life sciences industry. On behalf of these customers, Acino develops a comprehensive product pipeline on the basis of its special technological know-how. This includes both new types of medicines as well as projects with innovative drug delivery systems for established active ingredients. The production segment is responsible for the manufacturing of products and the supplying of the other three segments, and generates turnover through the reimbursement of its services. The manufacturing costs of products are credited to the production segment at standard prices along with remuneration in the form of a mark-up for materials and production costs.